Seeking Alpha

The FDA intends to allow generic pharmaceutical companies to alter the safety labels on their...

The FDA intends to allow generic pharmaceutical companies to alter the safety labels on their products if they become aware of new risks. The change could make the firms liable if they don't warn patients about the concerns about a product. Generic makers have been protected from such liability since 2011, when the Supreme Court said they couldn't be sued because they had to use the same labels as as their brand name counterparts. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs